Market News & Trends
Japanese Pharmaceutical Market Value Edging Toward $80 Billion
Japan’s pharmaceutical market value is set to grow at a tepid Compound Annual Growth Rate (CAGR) of 1.3% from $72.8 billion in 2013 to reach…
SGS Announces Amino Acid Analytical Services
SGS Life Science Services recently announced it is now able to offer a full range of analytical methods to identify amino acid impurities within pharmaceutical…
Novasep Selected to Commercially Biomanufacture Mydicar API
Novasep recently announced it has entered into an agreement with Celladon to supply the drug substance for MYDICAR. The €4.7M deal covers scale-up and prevalidation…
Midatech Pharma Poitive Study Results for OpsiSporin
Midatech Pharma recently announced positive results from a proof-of-concept in vivo study with OpsiSporin, a sustained-release treatment for uveitis. Uveitis is an inflammatory process affecting…
Significant Findings in US NIH's Trial of Pluristem's PLX-R18 Cells for Acute Radiation Syndrome
Pluristem Therapeutics Inc. recently announced the positive results of a recently completed trial conducted by the US National Institutes of Health (NIH) to evaluate PLX-R18…
N-of-One Becomes Oracle Silver Level Partner
N-of-One, Inc. recently announced it has become a Silver Partner in Oracle PartnerNetwork (OPN) Specialized program. By attaining Silver Level membership, N-of-One will benefit from…
Dipexium Pharmaceuticals Announces Successful Completion & Initial Results of Phase I Trial
Dipexium Pharmaceuticals, Inc. recently announced successful completion and initial results of DPX-120, a Phase I skin sensitization trial of Locilex (pexiganan cream 0.8%), the company's…
Ball Corporation Confirms Acquisition Terms of Rexam PLC
Ball Corporation and Rexam PLC recently announced the terms of a recommended offer by Ball to acquire all of the outstanding shares of Rexam in…
Aegis Awarded US Patent for Non- Invasive Delivery of Anti-Seizure Drugs
Aegis Therapeutics LLC recently announced it has been awarded US Patent No. 8,927,497 providing broad coverage for non-invasive delivery of anti-seizure drugs via a simple…
Senior Pharmaceutical Industry Executives Establish New Company & Business Model
Three highly experienced pharmaceutical and healthcare industry executives have formed next20, a new Thought Partnership, which provides strategic support to help healthcare and pharmaceutical companies…
Growth Hormone Therapy Market Favors Biobetters Over Biosimilars
The lack of biosimilars in the growth hormone deficiency (GHD) treatment pipeline does not signify a missed opportunity, because superior products exist in the form…
New Parsum IPP-80 In-Line Particle Sizing Probe: Robust, Trouble-Free Granulation Monitoring
The new Parsum IPP-80 probe from Malvern Instruments brings easy to integrate inline particle size measurement for efficient process monitoring and control. Suitable for powders,…
Needle-Free Technologies the Preferred Choice for Patients
BCC Research reveals in its new report on needle free technologies that during the past several decades, tremendous progress has been made toward the development…
With Stiff Competition From Biosimilars, Antibody Drugs Industry Revamping With Targeted Treatments
BCC Research reveals in its new report on antibody drugs that increasing competition and new technologies are propelling the market in a new direction. This…
Affinivax Announces Collaboration to Advance Lead Vaccine Candidate
Affinivax Inc. recently announced it has entered into a collaboration agreement with PATH, a global health nonprofit organization, to advance the company’s lead vaccine candidate…
SteadyMed Raises $12.2 Million
SteadyMed Ltd. recently announced it has secured $12.2 million in an equity financing. The financing was co-led by funds advised by subsidiaries of Federated Investors…
West Launches High-Quality Flip-Off Plus Seals
West Pharmaceutical Services, Inc. (NYSE: WST) recently announced the availability of a new sterile drug vial seal, the Flip-Off® PlusRU seal. Part of West’s Flip-Off®…
Noxilizer Announces Board of Directors Addition
Noxilizer, Inc. recently announced Herbert C. Buchanan Jr., President, IU Health Methodist and University Hospitals, will join its Board of Directors. The company plans to…
Vaxxas Raises $20 Million to Accelerate Commercialization of Novel Vaccine Platform
Vaxxas recently announced it has secured equity funding of $20 million from new and existing investors. These funds represent the first closing of a Series…
BioSpectra Welcomes New Director, Offering Direct Access to the Highest Compliance Excipients & APIs
BioSpectra recently announced the appointment of Thomas Donnelly as Director of Sales and Marketing. Mr. Donnelly will manage direct sales and business activities for BioSpectra…
